Tumor-reactive antibodies evolve from non-binding and autoreactive precursors
Roei David Mazor(Weizmann Institute of Science), Nachum Nathan(Weizmann Institute of Science), Amit Gilboa(Bar-Ilan University), Liat Stoler‐Barak(Weizmann Institute of Science), Lihee Moss(Weizmann Institute of Science), Inna Solomonov(Weizmann Institute of Science), Assaf Hanuna(Weizmann Institute of Science), Yalin Divinsky(Weizmann Institute of Science), Merav D. Shmueli(Weizmann Institute of Science), Hadas Hezroni(Weizmann Institute of Science), Irina Zaretsky(Weizmann Institute of Science), Michael Mor(Tel Aviv University), Ofra Golani(Weizmann Institute of Science), Gad Sabah(Tel Aviv University), Ariella Jakobson‐Setton(Tel Aviv University), Natalia Yanichkin(Tel Aviv University), Meora Feinmesser(Tel Aviv University), Daliah Tsoref(Tel Aviv University), Lina Salman(Tel Aviv University), Effi Yeoshoua(Tel Aviv University), Eyal Peretz(Rabin Medical Center), Inna Erlich(Rabin Medical Center), Netta Mendelson Cohen(Weizmann Institute of Science), Jonathan M. Gershoni(Tel Aviv University), Natalia T. Freund(Tel Aviv University), Yifat Merbl(Weizmann Institute of Science), Gur Yaari(Bar-Ilan University), Ram Eitan(Tel Aviv University), Irit Sagi(Weizmann Institute of Science), Ziv Shulman(Weizmann Institute of Science)
Cited by 158Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis